CDAN1

Across TCGA pan-cancer cohorts, CDAN1 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated CDAN1 data layer compared with 8 for mutation status and 2 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher CDAN1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CDAN1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

KICH, ACC, and LIHC are the cancer types where CDAN1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	II,III,IV	0.660	1.000	<.001	101	view →
ACC	DFS	Median	All	0.386	0.772	<.001	81	view →
LIHC	DFS	Tertile	All	0.403	0.591	<.001	79	view →
KIRC	DFS	Tertile	II,III,IV	0.436	0.658	.010	42	view →
BRCA	OS	Median	III,IV	0.961	0.845	<.001	34	view →
UCS	DFS	Quartile	III,IV	0.647	0.160	.002	28	view →
KIRP	DFS	Median	IV	0.036	0.528	.001	27	view →
LGG	DFS	Tertile	All	0.785	0.879	.005	21	view →
COAD	DFS	Median	III,IV	0.315	0.665	.006	20	view →
THYM	DFS	Quartile	All	0.967	0.760	.008	17	view →
GBM	DFS	Tertile	All	0.486	0.235	.006	15	view →
MESO	OS	Tertile	IV	0.226	0.954	.014	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

CDAN1–KICH (DFS)

Open the KICH breakdown →